Fierce Biotech December 5, 2023
Andrea Park

In the latter half of 2022, Rockley Photonics announced that it had signed the first commercial purchase order for its Bioptx biosensor-tracking wearables, with hopes of getting them on the first customers’ wrists by the end of the year and plans to majorly boost manufacturing throughout 2023.

Things didn’t go according to plan, however, as Rockley kicked off 2023 by filing for Chapter 11 bankruptcy in January. Nearly a year later, after wrapping up the bankruptcy proceedings over the summer and, according to the company, emerging with all of its material customer contracts and tech development programs still in place, Rockley is ready to return to the process of finding buyers for its Bioptx sensor.

According to a Tuesday announcement,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Technology, Wearables
Oura Ring Is ‘Like An Apple Product’ And Could Take Key Health Metric Mainstream
Wearable ultrasound sensor revolutionizes continuous blood pressure monitoring
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review

Share This Article